Journals / Turkish Journal of Pharmaceutical Sciences / 2021 / Cilt: 18 - Sayı: 2

Comparative Proteomic Analysis of Escherichia coli Under Ofloxacin Stress

Ofloksasin Stresi Altında Escherichia coli’nin Karşılaştırmalı Proteomik Analizi

Pages
21–26
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The results showed that ofloxacin affected many cellular processes and pathways.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In the present study, proteomics was utilized to evaluate changes in Escherichia coli proteins in response to ofloxacin to understand the mechanism of action of ofloxacin and the mechanisms of ofloxacin resistance in E. coli.
📊
Key Findings & Data:Results: In total, 649 common proteins were identified in the untreated and ofloxacin-treated groups, while 98 proteins were significantly different in the ofloxacin-treated group.
💡
Conclusion & Impact:Conclusion: The results showed that ofloxacin affected many cellular processes and pathways.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: In the present study, proteomics was utilized to evaluate changes in Escherichia coli proteins in response to ofloxacin to understand the mechanism of action of ofloxacin and the mechanisms of ofloxacin resistance in E. coli. Materials and Methods: Proteomics analysis of E. coli was performed by using liquid chromatography quadrupole time-of-flight mass spectrometry followed by a data processing step using MaxQuant. Functional classification and pathway analysis showed a systematic effect of ofloxacin over E. coli proteome structure. Results: In total, 649 common proteins were identified in the untreated and ofloxacin-treated groups, while 98 proteins were significantly different in the ofloxacin-treated group. Functional classification and pathway analysis showed that ofloxacin has a systematic effect over ribosomal processes, energy pathways (tricarboxylic acid cycle and glycolysis), membrane proteins, microbial targets, and biofilm formation. Conclusion: The results showed that ofloxacin affected many cellular processes and pathways. In addition, proteomic analysis revealed that E. coli develops resistance mechanism with different biological processes

Özet

Amaç: Bu çalışmada ofloksasinin etki mekanizmasına karşı yanıt olarak Escherichia coli proteinlerinde görülen değikliklerin belirlenmesi ve E. coli’deki oflotoksin direnç mekanizmalarının değerlendirilmesi için proteomiks kullanılmıştır. Gereç ve Yöntemler: E. coli’nin proteomik analizi sıvı kromatografisi/kuadrupol uçuş zamanlı kütle spektroskopisi kullanarak gerçekleştirilmiş ve sonrasında veri prosesleme aşaması MaxQuant kullanarak yapılmıştır. İşlevsel sınıflandırma ve yolak analizi oflotoksinin E. coli’nin proteome yapısına sistematik bir etkisinin olduğunu göstermiştir. Bulgular: Çalışmada 649 tane sıklıkla rastlanan proteinin yapısı oflotoksin ile muamele edilen ve edilmeyen gruplarda belirlenirken, 98 proteinin oflotoksin ile muamele gören grupta belirgin derecede farklı olduğunu göstermiştir. İşlevsel sınıflandırma ve yolak analizi oflotoksinin ribosomal prosesler, enerji yolakları (trikarboksilik asit siklusu ve glikoliz), membran proteinleri, mikrobiyal hedefler ve biofilm oluşumu üzerine sistematik bir etkisinin olduğunu göstermiştir. Sonuç: Bu sonuçlar ofloksasinin birçok hücresel prosesi ve yolağı etkilediğini göstermiştir. Ayrıca, proteomik analizler E. coli’nin farklı biyolojik prosesler ile direnç mekanizması geliştirdiğini göstermiştir.

🔖

Cite This Article

Ozkul, C., KOÇAK, E. (2022). Comparative Proteomic Analysis of Escherichia coli Under Ofloxacin Stress. Turkish Journal of Pharmaceutical Sciences, Cilt: 18 - Sayı: 2, 21–26. https://ajindex.com/articles/613636

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Pengelly A. Medicinal Plant: An Introduction to The Chemistry and Therapeutics of Herbal Medicine. 2nd ed. Crows Nest (AU); Allen & Unwin; 2004:133-140. [WHO] World Health Organization. World Malaria Report, 2016. Available from: http://www.who.int/malaria/publica-tions/world-malariareport-2016/report/en/
  2. Kushwah P, Das P, Badore NS, Salvekar V, Deshmukh N. Evaluation of antimicrobial activity of Cinchona calisaya bark on Staphylococcus by agar well diffusion method. Pharm Biol Eval. 2016;3:272-274.
  3. Krishnaveni M, Suresh K. Induction of apoptosis by quinine in human laryngeal carcinoma cell line. Int J Curr Res Aca Rev. 2015;3:169-178.
  4. Noriega P, Sola M, Barukcic A, Garcia K, Osorio E. Cosmetic antioxidant potential of extracts from species of the Cinchona pubescens (Vahl). Int J Phytocos Nat Ingred. 2015;2:14. Nair KPP. The agronomy and economy of important tree crops of the developing world. Burlington (US); Elsevier; 2010:112. Kacprzak K. Chemistry and biology of cinchona alkaloid. In Ramawat KG, Merillon JM, (eds). Natural Product. Heidelberg; Springer; 2013:605-641.
  5. Kumar S, Guha M, Choubey V, Maity P, Bandyopadhyay U. Antimalarial drugs inhibiting hemozoin (β hematin) formation: A mechanistic update. Life Sci. 2007;80:813-828.
  6. Kharal SA, Hussain Q, Ali S, Fakhuruddin. Quinine is bactericidal. J Pakistan Med Assoc. 2009;59:208-212.
  7. Wang S, Melkoumian Z, Woodfork KA, Cather C, Davidson AG, Wonderlin WF, Strobl JS. Evidence for an early G1 Ionic Event Necessary for cell cycle progression and survival in the MCF-7 human breast carcinoma cell line. J Celll Physiol. 1998;176:456-464. Kowey PR. Pharmacological effects of antiarrhytmic drugs. Arch Intercn Med. 1998;158:325-332. (FDA) Food Drug and Administration. Quinidine gluconate extendedrelease tablets USP, 2010. Available from: https://www.fda.gov/Food/
  8. Mathius NT, Lukman, Purwito A. In vitro micrografting technique of Cinchona succirubra with Cinchona ledgeriana. J Menara Perkebunan. 2006;74:63-75.
  9. Ratnadewi D, Sumaryono. Quinoline alkaloids in suspension cultures of Cinchona ledgeriana treated with various substances. Hayati J Biosci. 2010;17:179-182.
  10. Strobel G, Daisy B, Castillo U, Harper J. Natural products from endophytic microorganisms. J Nat Prod. 2004;67:257-268.
  11. Simanjuntak P, Parwati T, Bustanussalam, Prana TK, Shibuya H. Produksi alkaloid kuinina oleh beberapa mikroba endofit dengan penambahan zat induser (studi mikroba endofit tanaman Cinchona sp.). Indonesian J Pharm. 2002;13:1-6. Shibuya H